The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

Published:2005-12 Issue:12 Volume:23 Page:2157-2172
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Liu Lisheng,Zhang Yuqing,Liu Guozhang,Li Wei,Zhang Xuezhong,Zanchetti Alberto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference30 articles.

1. Global burden of hypertension: analysis of worldwide data;Kerney;Lancet,2005

2. Blood pressure and cardiovascular disease in the Asia Pacific Region.;J Hypertens,2003

3. Shanghai trial of nifedipine in the elderly (STONE);Gong;J Hypertens,1996

4. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension (Syst-China).;Liu;J Hypertens,1998

5. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report;Chobanian;JAMA,2003

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recreational beach tennis training reduces ambulatory blood pressure in adults with hypertension: a randomized clinical trial;Journal of Hypertension;2024-08-27

2. Recent Update on Diagnosis and Management of Hypertension: Based on the 2023 European Society of Hypertension Guidelines;Journal of the Korean Neurological Association;2024-08-01

3. 2023 Guideline for the management of hypertension in the elderly population in China;Journal of Geriatric Cardiology;2024-06

4. European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke;European Stroke Journal;2024-02-21

5. Management of Hypertension in the Asia-Pacific Region: A Structured Review;American Journal of Cardiovascular Drugs;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3